The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 17,401–17,500 of 31,469
Otani, M., Yamamoto, M., Harada, M., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00548.x · Cited by 16
Cholesterol Absorption and Synthesis in Pediatric Kidney, Liver, and Heart Transplant Recipients
Siirtola, A., ki, A. K., Miettinen, T. A., Gylling, H., Lehtimäki, T. J., Holmberg, C., Salo, M. K., & Antikainen, M. (2006) · Transplantation · doi:10.1097/01.tp.0000189173.46727.18 · Cited by 16
Brillante, D., O’Sullivan, A., Johnstone, M. T., et al. (2007) · Clinical Science · doi:10.1042/cs20070132 · Cited by 16
Leptin concentration indexed to fat mass is increased in untreated anorexia nervosa (AN) patients
Üzüm, A. K., Yücel, B., Ömer, B., İşsever, H., & Özbey, N. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03423.x · Cited by 18
Siirtola, A., Antikainen, M., Ala‐Houhala, M., et al. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00307.x · Cited by 16
Insulin resistence and health-related quality of life in postmenopausal women
Llaneza, P., González, C., Fernández-Iñarrea, J., Alonso, A., Arnott, I., & Ferrer-Barriendos, J. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.04.031 · Cited by 16
Tso, T. K., Huang, W.-N., Huang, H.-Y., & Chang, C.-K. (2006) · Lupus · doi:10.1191/0961203306lu2284oa · Cited by 16
Han, J. C., Damaso, L. C., Welch, S., et al. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.09.006 · Cited by 16
Lifecourse predictors of normal metabolic parameters in overweight and obese adults
Hayes, L. D., Pearce, M. S., & Unwin, N. C. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803213 · Cited by 16
Hsieh, C.-H., Wu, C.-Z., Hsiao, F.-C., Lin, J.-D., Li, J.-C., Wan, H.-L., Kuo, S.-W., Hung, Y.-J., Su, C.-C., & Pei, D. (2008) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2008.07.017 · Cited by 13
Bose, T., López-Alvarenga, J. C., Tejero, M. E., Voruganti, V. S., Proffitt, J. M., FREELAND-GRAVES, J. H., Cole, S. A., & Comuzzie, A. G. (2009) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2009.00379.x · Cited by 16
Diamanti‐Kandarakis, E., Livadas, S., Kandarakis, S., Papassotiriou, I., & Margeli, A. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345631 · Cited by 16
Heideman, W. H., de Wit, M., Middelkoop, B. J., Nierkens, V., Stronks, K., Verhoeff, A. P., & Snoek, F. J. (2015) · Patient Education and Counseling · doi:10.1016/j.pec.2014.12.008 · Cited by 16
van Vliet, M., Gazendam, R. P., von Rosenstiel, I. A., van Zanten, A. P., Brandjes, D. P. M., Beijnen, J. H., Rotteveel, J., & Diamant, M. (2010) · European Journal of Pediatrics · doi:10.1007/s00431-010-1323-3 · Cited by 16
Das, S., Bhoi, S. K., Baliarsinha, A. K., et al. (2007) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2006.0024 · Cited by 16
Altuntaş, Y., Bilir, M., Ozturk, B., & Gündoğdu, S. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00497-7 · Cited by 16
Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome
Ng, T. W. K., Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2009) · Clinical Science · doi:10.1042/cs20090110 · Cited by 17
Fardon, N. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02136-7 · Cited by 16
Møller, J. B., Overgaard, R. V., Madsen, H., et al. (2009) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-009-9145-5 · Cited by 16
Glucose intolerance in Japanese patients with polycystic ovary syndrome
Kurioka, H., Takahashi, K., & Miyazaki, K. (2006) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-006-0241-0 · Cited by 16
Andersen, O., Eugen‐Olsen, J., Kofoed, K., Iversen, J., & Haugaard, S. B. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.01.014 · Cited by 16
Zhang, X., Zhong-zhuan, L., Liu, D., Xu, X. Y., Shen, W., & Mei, Z. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05719.x · Cited by 16
Vaccaro, O., Cardoni, O., Cuomo, V., Panarelli, W., Laurenzi, M. W., Mancini, M., Riccardi, G., & Zanchetti, A. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01715.x · Cited by 16
Comucci, E. B., Vasques, A. C. J., Geloneze, B., Calixto, A., Pareja, J. C., & Tambascia, M. A. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000002431 · Cited by 16
Does birthweight predict adolescent adiponectin levels?
Kim, C. S., Park, J. S., Park, J., Nam, J. S., Kang, E. S., Ahn, C. W., Soo, B., Lim, S. K., Kim, K. R., Lee, H. C., et al. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02443.x · Cited by 17
Enriquez, Y. R., Giri, M., Rottiers, R., & Christophe, A. B. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.02.029 · Cited by 16
Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma
Papanastasiou, L., Παππά, Θ., Samara, C., Apostolopoulou, G., Tsiavos, V., Markou, Α., Alexandraki, K., Piaditis, G. P., Chrousos, G. P., & Kaltsas, G. (2012) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2012.02707.x · Cited by 17
Effects of steatosis on hepatic hemodynamics in patients with metabolic syndrome.
Soresi, M., Giannitrapani, L., Noto, D., Terranova, A., Campagna, M. E., Cefalù, A., Giammanco, A., & Montalto, G. (2015) · Ultrasound in Medicine and Biology · doi:10.1016/j.ultrasmedbio.2015.01.020 · Cited by 17
Park, K. S., Shin, H. D., Park, B. L., Cheong, H. S., Cho, Y., Lee, H. K., Lee, J., Lee, J., Kim, H.-K., Park, C. ‐., et al. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01882.x · Cited by 16
Appel, S. J. (2005) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2005.0052.x · Cited by 16
Katon, J. G., Flóres, Y. N., & Salmerón, J. (2009) · Salud Pública de México · doi:10.1590/s0036-36342009000300012 · Cited by 16
Fetal Programming of Type 2 Diabetes
Yajnik, C. S., Godbole, K., Otiv, S., & Lubree, H. (2007) · Diabetes Care · doi:10.2337/dc07-1485 · Cited by 17
Lin, S.-Y., Wang, Y.-Y., & Sheu, W. H. (2004) · Metabolism · doi:10.1016/j.metabol.2004.01.016 · Cited by 16
Derosa, G., D’Angelo, A., Fogari, E., et al. (2008) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2008.00984.x · Cited by 16
Kain, K., Catto, A. J., Young, J. B., et al. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00025-4 · Cited by 16
Salvatoni, A., Veronelli, E., Nosetti, L. M., et al. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346516 · Cited by 16
Lopes, P. A., Costa, A. S. H., Costa, P., et al. (2014) · animal · doi:10.1017/s1751731114000160 · Cited by 16
Efficacy of Benfluorex in Combination With Sulfonylurea in Type 2 Diabetic Patients
Moulin, P., André, M., Alawi, H., Santos, L. C., Khalid, A. K., Koev, D. J., Moore, R., Șerban, V., Picandet, B., & Leblond‐Francillard, M. (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-1439 · Cited by 16
Yoshimura, K., Hirano, S., Takata, H., Funakoshi, S., Ohmi, S., Amano, E., Nishi, Y., Inoue, M., Fukuda, Y., Hayashi, H., et al. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12622 · Cited by 16
Nepomuceno, R., Villela, B. S., Corbi, S. C. T., Bastos, A. D. S., dos Santos, R. A., Takahashi, C. S., Orrico, S. R. P., & Scarel‐Caminaga, R. M. (2017) · Mediators of Inflammation · doi:10.1155/2017/1491405 · Cited by 18
Psallas, M., Tentolouris, N., Papadogiannis, D. E., Doulgerakis, D. E., Kokkinos, A. D., Cokkinos, D. V., & Katsilambros, N. L. (2006) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.05.012 · Cited by 16
Effect of Physical Training on Insulin Resistance in Patients With Chronic Heart Failure
Nishiyama, Y., Minohara, M., Ohe, M., Hirai, Y., Katoh, A., Miyamoto, T., Iwami, G., Nakata, M., & Koga, Y. (2006) · Circulation Journal · doi:10.1253/circj.70.864 · Cited by 15
Dahan, M. H., & Goldstein, J. S. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.02.108 · Cited by 16
Nonalcoholic Steatohepatitis with Improved Hepatic Fibrosis after Weight Reduction
Fujikawa, K., Ohata, K., Honda, T., Miyazoe, S., Ichikawa, T., Ishikawa, H., Hamasaki, K., Nakao, K., Toriyama, K., & Eguchi, K. (2004) · Internal Medicine · doi:10.2169/internalmedicine.43.289 · Cited by 16
Guerci, B., Hadjadj, S., Quilliot, D., Ziegler, O., & Drouin, P. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430649 · Cited by 16
Derosa, G., D’Angelo, A., SALVADEO, S. A. T., Ferrari, I., Gravina, A., Fogari, E., Maffioli, P., & Cicero, A. F. G. (2008) · Metabolism · doi:10.1016/j.metabol.2008.06.010 · Cited by 16
Snehalatha, C., Ramachandran, A., Saltyamurthy, I., Satyavani, K., Sivasankari, S., Misra, J., & Viswanathan, V. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00541.x · Cited by 16
Kawamura, T., Egusa, G., Fujikawa, R., & Okubo, M. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00284-4 · Cited by 16
Décsi, T., Erhardt, É., Márkus, A., et al. (1999) · Acta Paediatrica · doi:10.1080/08035259950169495 · Cited by 16
Plasma Resistin, Insulin Concentration in Non-Diabetic and Diabetic, Overweight/Obese Thai
Chanchay, S., Tungtrongchitr, R., Harnroongroj, T., et al. (2006) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831.76.3.125 · Cited by 16
Solskov, L., Løfgren, B., Pold, R., Kristiansen, S. B., Nielsen, T. T., Overstreet, D. H., Schmitz, O., Bøtker, H. E., Lund, S. A., & Wegener, G. (2009) · Clinical Science · doi:10.1042/cs20090108 · Cited by 16
Persu, A., Vinck, W. J., Khattabi, O. E., Janssen, R. G. J. H., Paulussen, A. D. C., Devuyst, O., VLIETINCK, R. F., & Fagard, R. H. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000163144.74588.ad · Cited by 16
Schmid, C., Bianda, T., Zwimpfer, C., et al. (2005) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2005.06.012 · Cited by 16
Klannemark, M., Suurinkeroinen, L., Orho‐Melander, M., Groop, L., & Taskinen, M. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00343.x · Cited by 16
Watts, G. F. (2000) · QJM · doi:10.1093/qjmed/93.3.153 · Cited by 17
Lewis, J. G., Shand, B. I., Frampton, C. M., & Elder, P. A. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.03.021 · Cited by 16
Chan, L. C. K., Shaw, A. A., Busfield, F., Haluska, B. A., Barnett, A. G., Kesting, J. B., Short, L., Marczak, M., & Shaw, J. T. E. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.005 · Cited by 16
Metabolic characteristics of women who developed ovarian hyperstimulation syndrome
Delvigne, A. (2002) · Human Reproduction · doi:10.1093/humrep/17.8.1994 · Cited by 16
Melenovský, V., Malík, J., Wichterle, D., Šimek, J., Písaříková, A., Škrha, J., Poledne, R., Stávek, P., & Češka, R. (2002) · American Heart Journal · doi:10.1067/mhj.2002.124833 · Cited by 16
Giacco, R., Clemente, G., Busiello, L., Lasorella, G., Rivieccio, A., Rivellese, A. A., & Riccardi, G. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802306 · Cited by 15
Wierzbicki, A. S., Hardman, T. C., Cheung, J., et al. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02927-8 · Cited by 16
Król, E., Krejpcio, Z., & Iwanik, K. (2014) · Biological Trace Element Research · doi:10.1007/s12011-013-9877-3 · Cited by 16
Guinan, E. M., Hussey, J. M., McGarrigle, S. A., Healy, L., O'Sullivan, J. N., Bennett, K., & Connolly, E. M. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-138 · Cited by 17
Hunt, P. J., Gurnell, E. M., Huppert, F. A., Richards, C., Prevost, A. T., Wass, J. A. H., Herbert, J., & Chatterjee, V. K. K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7022 · Cited by 386
Bolatimi, O. E., Hua, Y., Ekuban, F. A., Gripshover, T. C., Ekuban, A., Luulay, B., Watson, W. H., Hardesty, J., & Wahlang, B. (2024) · Environment International · doi:10.1016/j.envint.2024.109152 · Cited by 15
Yang, M., Zhou, L., Long, G., Liu, X., Ouyang, W., Xie, C., & He, X. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s491300 · Cited by 17
Qiu, J., Li, J., Xu, S. M., Zeng, H., Zhang, Y., Yang, S., Fang, L., Huang, J., Zhou, H., Feng, J., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02674-z · Cited by 15
Li, J., 马南, Zhao, S., Zhang, X., Wan, J., Wan, J., Lin, R., Fan, F., Liu, G., Guan, S., et al. (2025) · Brain Circulation · doi:10.4103/bc.bc_32_24 · Cited by 15
Jardon, K. M. C., Umanets, A., Gijbels, A., Trouwborst, I., Hul, G. B. J., Siebelink, E., Vliex, L. M. M., Bastings, J. J. A. J., Argamasilla, R., Chenal, E., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2501185 · Cited by 18
Adherence to Mediterranean Diet and Implications for Cardiovascular Risk Prevention
Frank, G., Pala, B., Gualtieri, P., Tocci, G., Placa, G. L., & Renzo, L. D. (2025) · Nutrients · doi:10.3390/nu17121991 · Cited by 18
Soraneh, S., Ebrahimi, N., Masrouri, S., Tohidi, M., Azizi, F., & Hadaegh, F. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02944-w · Cited by 17
Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD
Lei, L., Wang, B., Zhao, L., Li, J., Yan, X., Jiang, J., Wang, L., Ren, G., Li, Y., Cheng, X., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.54152 · Cited by 19
Insulin resistance and coronary microvascular dysfunction: a complex interplay
Magistri, M., Portolan, L., Trevisanello, A., Tosi, F., Locatelli, A., Piana, S., Rubinelli, M., Molinaroli, E., Mantovani, A., Ribichini, F. L., et al. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03068-x · Cited by 16
Decreased microvascular myogenic response to insulin in severely obese adolescents
Montero, D., Walther, G., Pérez‐Martin, A., Santamaria, C., Roche, E., Mercier, C. S., & Vinet, A. (2014) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-131769 · Cited by 15
Yang, H. K., Min, K. W., Park, S. W., et al. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej14-0544 · Cited by 15
Circulating FABP4 and FABP5 Levels Are Differently Linked to OSA Severity and Treatment
Català, R., Cabré, A., Hernández-Flix, S., Ferré, R., Sangenís, S., Plana, N., Texidó, A., & Masana, L. (2013) · SLEEP · doi:10.5665/sleep.3210 · Cited by 15
Inoue, M. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.726614 · Cited by 15
Fat accumulates preferentially in the right rather than the left liver lobe in non-diabetic subjects
Hua, B., Hakkarainen, A., Zhou, Y., Lundbom, N. M. I., & Yki‐Järvinen, H. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.08.030 · Cited by 16
Derosa, G., Querci, F., Franzetti, I., Ragonesi, P. D., D’Angelo, A., & Maffioli, P. (2015) · Hypertension Research · doi:10.1038/hr.2015.57 · Cited by 14
Amirkhizi, F., Shahraki, S. H., Hosseinpour-Arjmand, S., & Ebrahimi‐Mameghani, M. (2018) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.65925 · Cited by 15
Halima, M. B., Kallel, A., Baara, A., Wafi, S. B., Sanhagi, H., Slimane, H., Jemaa, R., & Feki, M. (2018) · Biomarkers · doi:10.1080/1354750x.2018.1499129 · Cited by 15
Ranugha, P. S. S., Nithun, T., Betkerur, J. B., & Shastry, V. (2019) · Indian Dermatology Online Journal · doi:10.4103/idoj.idoj_303_18 · Cited by 15
Brassard, D., Laramée, C., Provencher, V., Vohl, M., Robitaille, J., Lemieux, S., & Lamarche, B. (2019) · Nutrition Journal · doi:10.1186/s12937-019-0474-y · Cited by 16
Geidenstam, N., Hsu, Y.-H. H., Astley, C. M., Mercader, J. M., Ridderstråle, M., Gonzalez, M. E., González, C., Hirschhorn, J. N., & Salem, R. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222445 · Cited by 16
Lee, I., Li, Y., & Sheu, W. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145008 · Cited by 15
Paiman, E. H. M., de Mutsert, R., Widya, R. L., Rosendaal, F. R., Jukema, J. W., & Lamb, H. J. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.07.011 · Cited by 16
Izumo, W., Higuchi, R., Yazawa, T., Uemura, S., Shiihara, M., & Yamamoto, M. (2020) · Pancreatology · doi:10.1016/j.pan.2020.08.005 · Cited by 15
Wahba, N. S., Ghareib, S. A., Abdel-Ghany, R. H., Abdel-Aal, M., & Alsemeh, A. E. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2020-0435 · Cited by 16
RetractedLin, Y.-F., Peng, K., Chang, C., Hu, Y., Wu, V., Chung, S., & Taiwan Primary Aldosteronism Investigation (TAIPAI) Study Group (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.797 · Cited by 17
Vertical sleeve gastrectomy induces distinctive transcriptomic responses in liver, fat and muscle
Ahn, C. H., Choi, E. H., Lee, H.-J., Lee, W., Kim, J., & Cho, Y. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-81866-5 · Cited by 16
Yi, X., Zhu, X., Zhou, Y., Zhang, D., Li, M., Zhu, Y.-T., & Guo, X.-M. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s291164 · Cited by 10
Ram, H., Jaipal, N., Kumar, P., Deka, P., Kumar, S., Kashyap, P., Kumar, S., Singh, B. P., Alqarawi, A. A., Hashem, A., et al. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666191203161509 · Cited by 15
Ayuob, N. N., Al‐Shathly, M. R., Bakhshwin, A., Al-Abbas, N. S., Shaer, N. A., Jaouni, S. K. A., & Hamed, W. H. E. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.664248 · Cited by 15
Li, S., Ma, L., Song, Y., Zheng, J., Cai, Y., Xu, H. A., Chen, P., Xu, W., Huang, Y., Qi, T., et al. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00784-9 · Cited by 15
Hirono, H., Watanabe, K., Hasegawa, K., Kohno, M., Terai, S., & Ohkoshi, S. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i19.5112 · Cited by 18
Choi, W., Park, J. Y., Hong, A. R., Yoon, J. H., Kim, H. K., & Kang, H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254630 · Cited by 15
Riveiro‐Barciela, M., Marcos‐Fosch, C., Martínez‐Valle, F., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i30.5112 · Cited by 15
de Lima, T. R., Sui, X., & Silva, D. A. S. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168428 · Cited by 16
Jamka, M., Morawska, A., Krzyżanowska-Jankowska, P., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168540 · Cited by 15
González-Casimiro, C. M., Cámara-Torres, P., Merino, B., Diez‐Hermano, S., Postigo, T., Leissring, M. A., Cózar‐Castellano, I., & Perdomo, G. (2021) · Cells · doi:10.3390/cells10092446 · Cited by 15
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
